The need to understand the intricate relationship between AR signaling and other molecular cascades involved with the pathogenesis of PCa and its therapeutic implications in advanced disease is of utmost importance, along with the familiarity of current and novel therapeutic approaches utilizing the AR signaling pathway for the treatment and management for patients with PCa in the advanced setting. This evidence concerns the gene AR and posterior cortical atrophy.